$24.95
1.27% yesterday
Nasdaq, Dec 02, 10:00 pm CET
ISIN
US74340E1038
Symbol
PGNY

Progyny Inc Stock price

$24.95
+6.52 35.38% 1M
+3.25 14.98% 6M
+7.70 44.64% YTD
+9.36 60.04% 1Y
-9.74 28.08% 3Y
-11.51 31.57% 5Y
+9.01 56.52% 10Y
+9.01 56.52% 20Y
Nasdaq, Closing price Tue, Dec 02 2025
-0.32 1.27%

New AI Insights on Progyny Inc Insights AI Insights on Progyny Inc

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$2.2b
Enterprise Value
$1.8b
Net debt
positive
Cash
$345.2m
Shares outstanding
86.2m
Valuation (TTM | estimate)
P/E
40.2 | 39.5
P/S
1.7 | 1.7
EV/Sales
1.4 | 1.4
EV/FCF
9.3
P/B
3.8
Financial Health
Equity Ratio
69.5%
Return on Equity
12.9%
ROCE
14.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.3b | $1.3b
EBITDA
$90.3m | $212.6m
EBIT
$85.8m | $208.3m
Net Income
$56.6m | $54.4m
Free Cash Flow
$193.5m
Growth (TTM | estimate)
Revenue
11.4% | 10.0%
EBITDA
31.9% | 201.1%
EBIT
31.1% | 208.8%
Net Income
-1.2% | 0.1%
Free Cash Flow
20.6%
Margin (TTM | estimate)
Gross
22.9%
EBITDA
7.1% | 16.6%
EBIT
6.8%
Net
4.5% | 4.2%
Free Cash Flow
15.3%
More
EPS
$0.6
FCF per Share
$2.2
Short interest
10.7%
Employees
678
Rev per Employee
$1.7m
Show more

Is Progyny Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,085 stocks worldwide.

Progyny Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Progyny Inc forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a Progyny Inc forecast:

Buy
63%
Hold
38%

Financial data from Progyny Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,269 1,269
11% 11%
100%
- Direct Costs 978 978
10% 10%
77%
291 291
18% 18%
23%
- Selling and Administrative Expenses 205 205
13% 13%
16%
- Research and Development Expense - -
-
-
90 90
32% 32%
7%
- Depreciation and Amortization 4.45 4.45
49% 49%
0%
EBIT (Operating Income) EBIT 86 86
31% 31%
7%
Net Profit 57 57
1% 1%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Progyny Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Progyny Inc Stock News

Positive
The Motley Fool
about 14 hours ago
CEO Anevski now owns $17 million worth of Progyny. Progyny's stock popped roughly 8% the day of the announcement.
Neutral
GlobeNewsWire
13 days ago
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in family building solutions, today announced new men's health research exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their role in the fertility journey and the barriers that prevent many from getting the care they need for successful conception.
Positive
Seeking Alpha
14 days ago
Progyny (PGNY) surges after strong Q3 earnings, robust client growth, and a $200M share buyback, signaling renewed momentum and market confidence. PGNY overcame Amazon's departure by adding new clients, achieving near 100% renewal rates, and accelerating revenue growth across both business segments. Analyst upgrades, insider buying, and secular tailwinds—like rising infertility and delayed chil...
More Progyny Inc News

Company Profile

Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

Head office United States
CEO Peter Anevski
Employees 678
Founded 2008
Website www.progyny.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today